Rapid characterization of non-volatile phenolic compounds reveals the reliable chemical markers for authentication of traditional Chinese medicine Xiang-ru among confusing Elsholtzia species
Zhen ZENG , Chen ZHANG , Jiadong HU , Feiyan WANG , Ziding WU , Jing WANG , Jun ZHANG , Shuda YANG , Junfeng CHEN , Mingming LI , Qi TONG , Shi QIU , Wansheng CHEN
Chinese Journal of Natural Medicines ›› 2024, Vol. 22 ›› Issue (4) : 375 -384.
The aerial parts of Mosla chinensis Maxim. and Mosla chinensis cv. 'Jiangxiangru' (MCJ) are widely utilized in traditional Chinese medicine (TCM), known collectively as Xiang-ru. However, due to clinical effectiveness concerns and frequent misidentification, the original plants have increasingly been substituted by various species within the genera Elsholtzia and Mosla. The challenge in distinguishing between these genera arises from their similar morphological and metabolic profiles. To address this issue, our study introduced a rapid method for metabolic characterization, employing high-resolution mass spectrometry-based metabolomics. Through detailed biosynthetic and chemometric analyses, we pinpointed five phenolic compounds—salviaflaside, cynaroside, scutellarein-7-O-D-glucoside, rutin, and vicenin-2—among 203 identified compounds, as reliable chemical markers for distinguishing Xiang-ru from closely related Elsholtzia species. This methodology holds promise for broad application in the analysis of plant aerial parts, especially in verifying the authenticity of aromatic traditional medicinal plants. Our findings underscore the importance of non-volatile compounds as dependable chemical markers in the authentication process of aromatic traditional medicinal plants.
Genus Elsholtzia / Genus Mosla / Traditional Chinese medicine / Xiang-ru / Non-volatile phenolic compounds / Liquid chromatography-mass spectrometry
| [1] |
Pharmacopoeia of the Peoples Republic of China[S]. Beijing: People’s Medical Publishing House, 2015, 1: 271. |
| [2] |
|
| [3] |
|
| [4] |
|
| [5] |
Pharmacopoeia of the Peoples Republic of China[S]. Beijing: People’s Medical Publishing House, 1997, 1: 420. |
| [6] |
Pharmacopoeia of the Peoples Republic of China[S]. Beijing: People’s Medical Publishing House, 1985, 1: 223. |
| [7] |
Pharmacopoeia of the Peoples Republic of China[S]. Beijing: People’s Medical Publishing House, 1990, 1: 230. |
| [8] |
|
| [9] |
|
| [10] |
|
| [11] |
|
| [12] |
|
| [13] |
|
| [14] |
|
| [15] |
|
| [16] |
|
| [17] |
|
| [18] |
|
| [19] |
|
| [20] |
|
| [21] |
|
National Key R&D Program of China(2022YFC3501700)
Young Elite Scientists Sponsorship Program by Cast(2021-QNRC1-02)
Ability Establishment of Sustainable Use for Valuable Chinese Medicine Resources(2060302)
Research Project of Science and Technology Commission of Shanghai Municipalit(21DZ2202300)
/
| 〈 |
|
〉 |